In Vitro & In Vivo Diagnostic Substances
17 companies in this industry report to the SEC and appear here. Together the 17 reporting revenue account for $10.42B in their latest annual periods. Each company is grouped by the Standard Industrial Classification code on its own filings, so the grouping is the regulator’s rather than ours. Figures are each company’s latest reported annual period; fiscal year ends differ.
| Company | Revenue | Net income | Total assets | Free cash flow |
|---|---|---|---|---|
| IDXXIDEXX LABORATORIES INC /DE | $4.30B | $1.06B | $3.35B | $1.06B |
| QDELQuidelOrtho Corp | $2.73B | -$1.13B | $5.77B | -$83.00M |
| LNTHLantheus Holdings, Inc. | $1.54B | $233.56M | $2.23B | Unavailable |
| NEOGNEOGEN CORP | $870.40M | -$7.90M | $3.35B | Unavailable |
| MYGNMYRIAD GENETICS INC | $824.50M | -$365.90M | $706.60M | Unavailable |
| NTLAIntellia Therapeutics, Inc. | $67.67M | -$412.69M | $842.13M | -$395.86M |
| TKNOAlpha Teknova, Inc. | $40.52M | -$17.26M | $103.58M | -$9.79M |
| ICCCIMMUCELL CORP /DE/ | $27.64M | -$1.04M | $42.53M | $1.22M |
| BMRABIOMERICA INC | $4.45M | -$3.78M | $6.76M | Unavailable |
| IMDXInsight Molecular Diagnostics Inc. | $4.06M | -$50.22M | $25.76M | -$25.37M |
| VNRXVOLITIONRX LTD | $1.73M | -$23.36M | $6.90M | -$19.77M |
| QCLSQ/C TECHNOLOGIES, INC. | $1.58M | -$3.89M | $10.88M | Unavailable |
| CLDXCelldex Therapeutics, Inc. | $1.54M | -$258.76M | $582.98M | -$213.66M |
| AWHLAspira Women's Health Inc. | $343.00K | -$12.78M | $5.46M | -$7.04M |
| CDIOCardio Diagnostics Holdings, Inc. | $14.82K | -$6.50M | $7.77M | -$5.91M |
| ACHVACHIEVE LIFE SCIENCES, INC. | $0 | -$16.40M | $21.08M | -$15.27M |
| BZYRBURZYNSKI RESEARCH INSTITUTE INC | $0 | -$1.39M | $847 | Unavailable |
Read the methodology for how these figures are selected, or browse screens that cut across industries.